Your browser doesn't support javascript.
loading
Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3): A randomized, double-blind, placebo-controlled, phase III trial.
Wang, Weimin; Yan, Xin; Cheng, Zhifeng; Zhang, Qiqi; Wang, Rui; Deng, Yuying; Ma, Jianhua; Zhu, Dalong.
Afiliação
  • Wang W; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
  • Yan X; Department of Endocrinology, Jinan Central Hospital, Jinan, China.
  • Cheng Z; Department of Endocrinology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhang Q; Lilly China Drug Development and Medical Affairs Centre, Eli Lilly (Suzhou) Pharmaceutical Co., Ltd, Shanghai, China.
  • Wang R; Lilly China Drug Development and Medical Affairs Centre, Eli Lilly (Suzhou) Pharmaceutical Co., Ltd, Shanghai, China.
  • Deng Y; Lilly China Drug Development and Medical Affairs Centre, Eli Lilly (Suzhou) Pharmaceutical Co., Ltd, Shanghai, China.
  • Ma J; Department of Endocrinology, Nanjing First Hospital, Nanjing, China.
  • Zhu D; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Diabetes Obes Metab ; 25(12): 3690-3699, 2023 12.
Article em En | MEDLINE | ID: mdl-37732487
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos Fc das Imunoglobulinas / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Hipoglicemia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos Fc das Imunoglobulinas / Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon / Hipoglicemia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China